A Phase II Study of Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer.
Phase of Trial: Phase II
Latest Information Update: 14 Jun 2017
At a glance
- Drugs Paclitaxel (Primary) ; Pazopanib (Primary)
- Indications Bladder cancer; Urethral cancer; Urogenital cancer
- Focus Therapeutic Use
- 08 May 2017 Status changed from active, no longer recruiting to completed.
- 08 Jul 2014 Planned End Date changed from 1 Dec 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 26 Apr 2014 Status changed from recruiting to active, no longer recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History